Accurate quantification of dystrophin mRNA and exon skipping levels in duchenne muscular dystrophy.
about
Targeted skipping of human dystrophin exons in transgenic mouse model systemically for antisense drug developmentThe effect of 6-thioguanine on alternative splicing and antisense-mediated exon skipping treatment for duchenne muscular dystrophyRescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skippingIn-frame dystrophin following exon 51-skipping improves muscle pathology and function in the exon 52-deficient mdx mouse.Generation of embryonic stem cells and mice for duchenne research.Autophagy is Impaired in the Tibialis Anterior of Dystrophin Null MiceDigital Droplet PCR for the Absolute Quantification of Exon Skipping Induced by Antisense Oligonucleotides in (Pre-)Clinical Development for Duchenne Muscular Dystrophy.Accurate Quantitation of Dystrophin Protein in Human Skeletal Muscle Using Mass SpectrometryNovel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agentsElectroporation Enhanced Effect of Dystrophin Splice Switching PNA Oligomers in Normal and Dystrophic Muscle.New function of the myostatin/activin type I receptor (ALK4) as a mediator of muscle atrophy and muscle regeneration.The Dynamics of Compound, Transcript, and Protein Effects After Treatment With 2OMePS Antisense Oligonucleotides in mdx Mice.Antisense-induced myostatin exon skipping leads to muscle hypertrophy in mice following octa-guanidine morpholino oligomer treatment.Engineering multiple U7snRNA constructs to induce single and multiexon-skipping for Duchenne muscular dystrophy.Long-term Exon Skipping Studies With 2'-O-Methyl Phosphorothioate Antisense Oligonucleotides in Dystrophic Mouse Models.Prednisolone treatment does not interfere with 2'-O-methyl phosphorothioate antisense-mediated exon skipping in Duchenne muscular dystrophyA dystrophic Duchenne mouse model for testing human antisense oligonucleotides.Analysis of extracellular mRNA in human urine reveals splice variant biomarkers of muscular dystrophies
P2860
Q28478166-65F39D9F-487B-4966-913D-EA5B12556B37Q28484390-793C21B1-9140-4731-9E12-46ADA5CE4814Q30514014-3C5FF6FA-A4A5-41E1-B60A-9936A78D46CBQ34343780-3916C20C-B7F1-43B6-9F5D-AAA20B21F273Q34993910-559173A0-1787-4888-A448-B3CACB3C3AE3Q35057217-BBD0C814-08A8-4E0B-B9E5-0793DDA06C3CQ36128670-71121001-39A1-43E7-871C-D1F7B6971081Q36812936-751B22AD-6D60-468D-AFF9-004E1DD59BC4Q36925191-834747E0-C951-4C64-82E2-1D84A50BACE5Q37238941-2A737FA0-0B0E-4C69-9D5A-A879D0761B43Q37510390-77298B08-7933-44AB-8E40-76FB14ED5EB4Q38257312-68C4752E-1D45-4618-B4D1-730606E65268Q38340328-4478AFD5-E941-48A5-B2ED-5CF947D7019FQ39392603-9E79AD20-DC83-4154-9595-F986E582660BQ42507352-86C62955-FB89-4888-A77E-2FE5225527CFQ42587467-85ED6F59-07E1-4C0B-B3A5-85A4D887B697Q52688621-59420BF2-D385-4D45-AF13-7C02D37B87F9Q56936089-8628544A-1EC3-438B-B02B-A5BCFB61115C
P2860
Accurate quantification of dystrophin mRNA and exon skipping levels in duchenne muscular dystrophy.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Accurate quantification of dys ...... n duchenne muscular dystrophy.
@en
Accurate quantification of dys ...... n duchenne muscular dystrophy.
@nl
type
label
Accurate quantification of dys ...... n duchenne muscular dystrophy.
@en
Accurate quantification of dys ...... n duchenne muscular dystrophy.
@nl
prefLabel
Accurate quantification of dys ...... n duchenne muscular dystrophy.
@en
Accurate quantification of dys ...... n duchenne muscular dystrophy.
@nl
P2093
P2860
P50
P1476
Accurate quantification of dys ...... in duchenne muscular dystrophy
@en
P2093
Alessandra Ferlini
Hans Heemskerk
Johan T den Dunnen
Rolf H A M Vossen
P2860
P2888
P304
P356
10.1038/LABINVEST.2010.98
P407
P577
2010-05-10T00:00:00Z